Boston Millennia Partners

Boston Millennia Partners is a growth equity firm established in 1997 and based in Boston, Massachusetts. The firm specializes in investment opportunities across the healthcare, information technology, business services, telehealth, and behavioral health sectors. With a focus on growth capital investing, Boston Millennia Partners leverages its extensive network and deep industry expertise to create meaningful contributions to its portfolio companies. The firm is particularly interested in outsourcing and software as a service businesses. By actively engaging with entrepreneurs, Boston Millennia Partners aims to foster enduring, large-scale enterprises that offer both personal fulfillment and strong financial returns. Over its more than thirty-year history, the firm has developed a collaborative approach, striving to build supportive and productive relationships that generate long-term value for its business partners.

Pat Fortune

Operating Partner

Hernon J.D., Martin J.

General Partner

Robert Jevon

Partner

Steven Labkoff

Venture Affiliate

Lipset M.B.A., Craig

Venture Affiliate

Willie Muehlhausen

Venture Affiliate

Ren Roome

Principal

Bruce Tiedemann

Partner / CFO

129 past transactions

KAID Health

Series A in 2022
KAID Health offers and specializes in artificial intelligence and natural language processing for healthcare organizations. KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve.

Huma.AI

Series A in 2022
Healthcare is extremely inefficient due to complex and disparate systems that don’t talk to each other. The explosion of data further compounds the problem. Huma.AI improves (if not solves) this inefficiency by serving as the connective tissue between system silos allowing “mere mortals” to automatically access data, gain insights and take action using everyday language.

Reveleer

Venture Round in 2021
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control of their risk adjustment and quality improvement programs. The platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction, and reporting – all under one single platform.

CareAlign

Seed Round in 2021
CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.

BEKHealth

Seed Round in 2021
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to help organizations conducting clinical trials and observational studies better understand their patient populations, optimize feasibility, speed up site selection, and rapidly identify clinically qualified participants by extracting structured and unstructured data from electronic medical records (EMRs) that captures three times more trial criteria. With BEKhealth by your side, dramatically speed up feasibility and detect more protocol-eligible candidates leading to 10x more qualified patients and 2x faster enrollment.

Clinical Research IO

Series A in 2021
Clinical Research IO is a health tech company developing eSource technology to streamline clinical research workflow. It assists pharma, biotech, research sites, and academic research centers streamlines regulatory workflows with one system that enables a single point of data capture.

Turbine

Seed Round in 2021
Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutic targets or indications, untangling the complexity of cancer.

SomaLogic

Series A in 2020
SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

COTA Healthcare

Series D in 2020
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.

Cecelia Health

Series B in 2020
Cecelia Health is tech-enabled diabetes and chronic disease management company that combines technology with expert clinical coaching. It aims to transform the lives and health outcomes of people with diabetes, obesity, cardiovascular disease, and other chronic conditions. Cecelia Health helps people with chronic conditions adhere to their medications and related nutrition, health, and wellness programs. During COVID-19, Cecelia Health has also been offering telehealth support to patients. It was founded in 2009 and headquartered in New York, United States.

CareAlign

Seed Round in 2020
CareAlign provides clinicians with an intuitive, patient-centric task management tool to track, manage and coordinate clinical care. Easily assign, date and time tasks, categorize them for when they are due, view cleared tasks and more.

iQuartic

Venture Round in 2020
iQuartic Inc. develops cloud platforms to network and data mine EHR and other data for the healthcare industry. Its technology enables EHR and claims auditing, quality benchmarking, population health management, disease management, risk profiling, and P4P revenue optimization. It provides iQ EHR Network, a vendor-agnostic EHR networking coupled with analytics processing real time data to network and integrate disparate EMR systems from multiple facilities; iQ EHR Auditing, a technology that applies advanced analytics and text mining to uncover inconsistencies in EHR and claims data; iQ ACO Software, which enables accountable care organizations (ACO) to achieve an analytical view of entire networks and individual patients; iQ EHR Data Mining, which are predictive modeling modules for quality benchmarking, risk profiling, disease management, and other applications; and iQ EHR Reporting, which enables system-wide assessment of use and financial impact of non-compliance. The company’s products include EHR Data Auditor, an EHR analytics platform used for behavior modeling of patient groups to identify an under-reporting of HIV+ patients; Diabetes Management Scorecard, a technology used to assess diabetes management across a network of disparate EMRs; COPD Population Profiler, a technology focused on chronic disease management, and to predict and manage COPD patients; Readmission Predictor, a platform based on EMR integration framework to provide a predictive modeling plug-and-play module for predicting patients at risk for hospital re-admission; Predictive Claims Auditor, an EMR integration framework to detect and prevent erroneous clinical data entries; Predictive Patient Outreach, which is used to predict optimal targets and channels for marketing initiatives; and Clinician Profiler, an integrated system for profiling clinicians, calculating practice variations, and assessing risk. The company was incorporated in 2012 and is based in Cambridge, Massachusetts.

Health Decisions

Venture Round in 2020
Health Decisions is a full-service CRO specializing in clinical studies of therapeutics for women’s health indications and studies of diagnostics for all therapeutic areas. Health Decisions has focused on women’s health since its inception more than 28 years ago, conducting more than 100 trials in women-only indications such as contraception and postmenopausal vasomotor symptoms. More than a decade ago, Health Decisions expanded into diagnostics studies with a large PMA study of a screening test for high-risk HPV types – the precursors of cervical cancer. Building on the success of the HPV study, Health Decisions has conducted successful diagnostics studies in a variety of other indications in women’s health and beyond, including diagnostics for risk of preterm birth, STIs, a variety of respiratory indications and oncology indications such as colorectal cancer and urothelial carcinoma. Health Decisions has provided services enabling many developers of both women’s health products and diagnostics to meet their development and business goals and looks forward to successful collaborations with many more. They take pride in offering the flexibility to tailor services to each sponsor in a manner that builds on the strengths of both development partners.

Digital Cognitive Technologies

Venture Round in 2020
DCT develops tests that detect presymptomatic cognitive impairment and aid in tracking cognitive change.

Reveleer

Series C in 2019
Reveleer is a healthcare software and services company that empowers payers in all lines of business to take control of their risk adjustment and quality improvement programs. The platform enables payers to independently execute and manage every aspect of provider outreach, retrieval, coding, abstraction, and reporting – all under one single platform.

Forefront TeleCare

Series A in 2019
Forefront TeleCare, Inc. is a pioneer and U.S. leader in the delivery of behavioral health services to small, rural healthcare facilities via our unique HIPAA-compliant TeleCare service which incorporates software, hardware, and comprehensive service protocols. Our current specialty services include psychiatry and clinical psychology, and we expect to begin delivering both physiatry and advanced wound care services by early 2014. Our client facilities include skilled nursing facilities and clinics in 18 states from coast to coast. Our Forefront Provider Network currently includes psychiatrists, clinical psychologists, and psychiatric nurse practitioners.

Roobrik

Venture Round in 2018
Roobrik builds online assessment and decision tools for adults and their caregivers. The company prioritizes informed decision-making by offering assessment tools to older adults and families. Roobrik was founded in 2013 and is headquartered in Greensboro, North Carolina.

COTA Healthcare

Series C in 2018
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.

Mingle Health

Venture Round in 2018
Mingle Health develops an end-to-end quality-improvement platform that simplifies data collection, reporting, and preventive care. The company was founded in 2011 and is headquartered in Sandy, Utah, United States.

C2Sense

Seed Round in 2017
C2Sense is currently working to bring two products to market: Halo Diagnostics, a digitally connected immunoassay reader with a user-friendly hardware and software, provide near-PCR sensitivity to address the gap in the patient-to-provider workflow. The Halo hardware is supported by a cloud-based, HIPAA compliant software solution that provides real-time test results to patients using an app (iOS/Android) or a web portal and, simultaneously, can be shared with a Telehealth physician to expedite time sensitive therapeutic prescriptions. To rapidly scale this technology, C2Sense partners with with immunoassay test manufacturers that own large portfolios of antigen tests that, pre-pandemic, had been exclusively providing tests to hospitals and urgent care facilities. By pairing these tests with a digitally enabled, highly sensitive test readers, remote physicians have access to store and review the same test results their patients are seeing in real time. In conjunction with Halo, C2Sense has designed different sensing solutions to provide product quality information and counterfeit detection from the point of manufacturing out to the customer. Discretely printed onto or included in a product, the tags are safe, versatile molecular additives that instantaneously report valuable information about the status of a good. They identify counterfeits and, where required, they are designed to react to problems encountered in the distribution chain (temperature change, oxygen sensing, and more). The tags are compatible with products as small as a pill, or can coat entire packaging surfaces, enabled by the tags’ compatibility with a myriad of printing and coating techniques.

Bivarus

Series B in 2017
Bivarus was born from academic research around the patient experience, which identified it as an integral factor in understanding patient outcomes. In fact, patient experience proved to be an independent predictor of health outcomes compared with other clinical process measures. As healthcare leaders they were frustrated by our inability to acquire statistically precise, actionable data around the patient experience. Traditional approaches were burdensome to patients, plagued by low response rates, and frankly, neither timely nor actionable. Today, Bivarus illuminates insights healthcare leaders need to quickly improve their patient experience. Bivarus offers a new approach that captures and delivers targeted and meaningful patient insights in real time. Healthcare leaders leverage Bivarus’s cloud-based analytics platform to identify service issues at their root cause, evaluate provider performance and track quality improvement efforts instantly, rather than in hindsight. In addition, Bivarus is a CMS-approved CAHPS® partner and provides comprehensive services for measuring employee perceptions around organizational effectiveness, culture, leadership and safety and support for improving engagement across healthcare organizations.

COTA Healthcare

Series B in 2016
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.

BC Platforms

Venture Round in 2016
BCP provides a unique data and technology platform to enable life sciences and healthcare companies to access, manage and analyze clinical and omics data. BCP’s Data Access Platform provides access and related technology to valuable data (RWD, Clinical, Genomics, and Omics) for the Life Science Industry. The Company’s Data Partner Network currently covers more than 22m life-years of highly curated patient data from around the world and is steadily growing. These data are made accessible to Pharma companies through a data-as-a-service (DaaS) model. BCP is able to provide Life Science companies with transformational capabilities to access longitudinal clinical and genome data across the globe to enhance different use cases within the R&D continuum, speeding up the process from early discovery to clinical and post-market access processes. BCP’s technology platform provides technology to Healthcare Providers and Life Science companies to produce, manage and analyze complex genomics as a clinical decision-support solution, analyze the data (genomics- omics and clinical) and make it available for any research ensuring compatibility with all relevant technical standards and in compliance with local privacy law in different jurisdictions.

Bivarus

Series A in 2016
Bivarus was born from academic research around the patient experience, which identified it as an integral factor in understanding patient outcomes. In fact, patient experience proved to be an independent predictor of health outcomes compared with other clinical process measures. As healthcare leaders they were frustrated by our inability to acquire statistically precise, actionable data around the patient experience. Traditional approaches were burdensome to patients, plagued by low response rates, and frankly, neither timely nor actionable. Today, Bivarus illuminates insights healthcare leaders need to quickly improve their patient experience. Bivarus offers a new approach that captures and delivers targeted and meaningful patient insights in real time. Healthcare leaders leverage Bivarus’s cloud-based analytics platform to identify service issues at their root cause, evaluate provider performance and track quality improvement efforts instantly, rather than in hindsight. In addition, Bivarus is a CMS-approved CAHPS® partner and provides comprehensive services for measuring employee perceptions around organizational effectiveness, culture, leadership and safety and support for improving engagement across healthcare organizations.

Collegium Pharmaceutical

Venture Round in 2015
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.

G-Form

Venture Round in 2015
G-Form is a technology-driven protective solutions provider.G-Form is a chosen protective equipment brand for a variety of team sports, such as baseball, soccer, hockey, and basketball, as well as action sports, such as mountain biking skiing, and snowboarding. G-Form also creates superior protective solutions for the military, law enforcement, and industrial applications.

Avhana Health

Seed Round in 2014
Avhana Health operates a value-based care enablement platform. It is driven by a mission to offer impactful, patient-specific support for healthcare teams. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Odyssey Logistics & Technology

Venture Round in 2014
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Odyssey Logistics & Technology

Venture Round in 2014
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

PreCision Dermatology

Debt Financing in 2013
PreCision Dermatology is a fully-integrated dermatology company with a mission to deliver innovative therapies to doctors and patients that demonstrably improve the care of skin. PreCision Dermatology is expanding rapidly through internally generated innovation, acquisitions, in-licensing, and co-marketing opportunities.

Histogenics

Series C in 2012
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Collegium Pharmaceutical

Venture Round in 2012
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.

NuVox

Venture Round in 2012
Windstream Communications provides voice and data network communications, and managed services to businesses in the United States.

Odyssey Logistics & Technology

Venture Round in 2010
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

SensorLogic

Venture Round in 2010
SensorLogic provides M2M application hosting and the only PaaS (platform-as-a-service) provider that offers easily customizable M2M solutions with a pre-integrated nation-wide GSM/GPRS network. Customers using Sensorlogic's XpressIQ Service Suite have access to ready-to-use applications for GPS tracking, asset monitoring and control, as well as value-added network services

Nexidia

Series F in 2010
Nexidia has delivered a platform that unlocks the untapped value inside the massive amounts of unstructured audio and video content by making it searchable and enabling you to achieve competitive advantages, operational efficiencies, and new business opportunities.

CardioMEMS

Venture Round in 2010
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Coapt Systems

Debt Financing in 2009
Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

CardioMEMS

Series F in 2009
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

MedAptus

Venture Round in 2009
MedAptus, Inc. provides point-of-care charge capture technologies. MedAptus offers Practice Plus Edition, a solution that is uses at single-specialty groups, multi-specialty clinics, and academic practice plans; Inpatient Edition for hospitalists, intensivists, and anesthesiologists to ease patient management tasks in addition to ensuring charge capture; EMR Edition, which is designed for physician groups; Enterprise Edition, which is designed for large groups, including academic centers and integrated delivery networks; Facility Edition that is created for hospital-based outpatient clinics to eliminate paper, manual coding and charge reconciliation, and charge data master maintenance processes from daily workflow; and Infusion Services Edition that supports the capture of infusion services and related charges allowing nurses to spend less time on paperwork and more time with patients. The company serves customers, such as smaller single specialty practices, larger multi-specialty groups, and academic medical centers. MedAptus, Inc. was formerly known as MedCompanion, Inc.

Histogenics

Series B in 2008
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace. Our regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions. Our first investigational product candidate, NeoCart®, leverages our platform to provide an innovative treatment in the orthopedic space, specifically cartilage damage in the knee.

Collegium Pharmaceutical

Series D in 2008
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.

SensorLogic

Series C in 2008
SensorLogic provides M2M application hosting and the only PaaS (platform-as-a-service) provider that offers easily customizable M2M solutions with a pre-integrated nation-wide GSM/GPRS network. Customers using Sensorlogic's XpressIQ Service Suite have access to ready-to-use applications for GPS tracking, asset monitoring and control, as well as value-added network services

Arthrosurface

Series F in 2008
Founded in 2002, Arthrosurface quickly became a globally recognized name and leader in joint preservation and replacement technology for the treatment of osteoarthritis. Arthrosurface offers anatomic, minimally invasive joint replacement solutions clinically proven to help patients stay active by increasing range of motion and reducing pain. The uniquely designed implant systems preserve native joint anatomy and maintain normal biomechanics across multiple joints. Patients can expect a short hospital stay, quick recovery, improved range of motion, reduced pain and a return to full activity levels, including CrossFit, Powerlifting or simply daily tasks necessary for an independent lifestyle. #StayActive

MedAptus

Venture Round in 2007
MedAptus, Inc. provides point-of-care charge capture technologies. MedAptus offers Practice Plus Edition, a solution that is uses at single-specialty groups, multi-specialty clinics, and academic practice plans; Inpatient Edition for hospitalists, intensivists, and anesthesiologists to ease patient management tasks in addition to ensuring charge capture; EMR Edition, which is designed for physician groups; Enterprise Edition, which is designed for large groups, including academic centers and integrated delivery networks; Facility Edition that is created for hospital-based outpatient clinics to eliminate paper, manual coding and charge reconciliation, and charge data master maintenance processes from daily workflow; and Infusion Services Edition that supports the capture of infusion services and related charges allowing nurses to spend less time on paperwork and more time with patients. The company serves customers, such as smaller single specialty practices, larger multi-specialty groups, and academic medical centers. MedAptus, Inc. was formerly known as MedCompanion, Inc.

CardioMEMS

Series E in 2007
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Infotrieve

Series C in 2007
Infotrieve, Inc., an information management company, provides consulting and business service solutions for information centers in large and middle-market corporations. It offers librarians solutions, such as document delivery services; library staffing and information management services; STM Library, which provides real estate, technology, and personnel for collection management and document delivery for scientific, technical, and medical industries; Virtual Library 2.0, a document sourcing/delivery platform which automates and manages the document delivery process at the division or departmental level in large companies, or as an enterprise solution for a medium size or small companies; Ariel Interlibrary Loan Document Transmission Software, which turns personal computers, printers, and scanners into a document transmission station on the Internet; and copyright compliance services. The company also provides information center management solutions, such as business process outsourcing services; and Content SCM, which is designed to manage content sourcing and delivery at the enterprise level for large companies. In addition, it offers product and marketing manager’s solutions, such as reprints, eprints, and permissions services; and BRAVO, which enables colleagues separated by department, divisions, or continents to exchange communications about reprint orders in process; and eDetailing, a communication tool for pharmaceutical product and marketing managers. Infotrieve, Inc. was founded in 1987 and is headquartered in Wilton, Connecticut.

Arthrosurface

Series F in 2007
Founded in 2002, Arthrosurface quickly became a globally recognized name and leader in joint preservation and replacement technology for the treatment of osteoarthritis. Arthrosurface offers anatomic, minimally invasive joint replacement solutions clinically proven to help patients stay active by increasing range of motion and reducing pain. The uniquely designed implant systems preserve native joint anatomy and maintain normal biomechanics across multiple joints. Patients can expect a short hospital stay, quick recovery, improved range of motion, reduced pain and a return to full activity levels, including CrossFit, Powerlifting or simply daily tasks necessary for an independent lifestyle. #StayActive
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Xconomy

Series A in 2007
Xconomy is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. We are the authoritative voice on the exponential economy, the realm of business and innovation characterized by exponential technological growth and responsible for an increasing share of productivity and overall economic growth. We deliver this valuable content through a unique global network of localized news sites, events, conferences, and other initiatives designed to better connect people and ideas.

SensorLogic

Series B in 2007
SensorLogic provides M2M application hosting and the only PaaS (platform-as-a-service) provider that offers easily customizable M2M solutions with a pre-integrated nation-wide GSM/GPRS network. Customers using Sensorlogic's XpressIQ Service Suite have access to ready-to-use applications for GPS tracking, asset monitoring and control, as well as value-added network services

Coapt Systems

Series E in 2007
Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilization trays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.

CardioMEMS

Series D in 2006
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Collegium Pharmaceutical

Series C in 2006
Collegium Pharmaceutical is a specialty pharmaceutical company focused on the development of proprietary, late-stage pharmaceutical products. These products address the growing problems associated with non-medical use and abuse of prescription drugs through formulation based improvements protected by intellectual property (IP). Collegium is focused on building a portfolio of products for the treatment of chronic pain that possess tamper-resistant features and provide extended-release delivery using its patent-protected DETERx formulation platform.

Nexidia

Series E in 2006
Nexidia has delivered a platform that unlocks the untapped value inside the massive amounts of unstructured audio and video content by making it searchable and enabling you to achieve competitive advantages, operational efficiencies, and new business opportunities.

Athenix

Series C in 2006
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

GlycoFi Inc.

Series C in 2005
GlycoFi is a biotech firm that develops biotherapeutics based on the glycan optimization technology. The firm aims to develop its own pipeline of therapeutic proteins and team with other drug-makers to develop products. GlycoFi has developed a protein manufacturing process using yeast-based glycolysation where the resulting proteins can be used in drug development. GlycoFi was incorporated in 2000 and is based in Lebanon, New Hampshire. As of June 6, 2006, GlycoFi, Inc. operates as a subsidiary of Merck & Co. Inc.

Nexidia

Series D in 2005
Nexidia has delivered a platform that unlocks the untapped value inside the massive amounts of unstructured audio and video content by making it searchable and enabling you to achieve competitive advantages, operational efficiencies, and new business opportunities.

Novalar Pharmaceuticals

Series C in 2005
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Netifice Communications

Venture Round in 2005
Netifice Communications is redefining how Managed Service Providers deliver secure IP data and voice communication services.

Arthrosurface

Venture Round in 2005
Founded in 2002, Arthrosurface quickly became a globally recognized name and leader in joint preservation and replacement technology for the treatment of osteoarthritis. Arthrosurface offers anatomic, minimally invasive joint replacement solutions clinically proven to help patients stay active by increasing range of motion and reducing pain. The uniquely designed implant systems preserve native joint anatomy and maintain normal biomechanics across multiple joints. Patients can expect a short hospital stay, quick recovery, improved range of motion, reduced pain and a return to full activity levels, including CrossFit, Powerlifting or simply daily tasks necessary for an independent lifestyle. #StayActive
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Fast Channel Network

Venture Round in 2005
FastChannel provides innovative, technology-based solutions to help advertisers and agencies work faster, smarter and more competitively. Through the FastChannel Intelligence and Control platform customers leverage an integrated suite of intelligence and workflow tools designed specifically for the advertising industry—competitor tracking, creative and production resourcing, broadcast verification, and digital asset management. The company also features an online media distribution network, with more than 5,000 advertisers and agencies, and 21,000 online broadcast and publishing destinations.

SensorLogic

Series A in 2004
SensorLogic provides M2M application hosting and the only PaaS (platform-as-a-service) provider that offers easily customizable M2M solutions with a pre-integrated nation-wide GSM/GPRS network. Customers using Sensorlogic's XpressIQ Service Suite have access to ready-to-use applications for GPS tracking, asset monitoring and control, as well as value-added network services

Rejuvenon

Series B in 2004
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.

Tropos Networks

Series D in 2004
Tropos Networks is a supplier of systems used to build metro-scale Wi-Fi networks. Tropos' products enable network operators, service providers and government departments to provide ubiquitous, metro-scale, broadband, wireless data coverage for users in any locale. Tropos' solution creates a truly wireless network, free from the requirement of per node wired connectivity associated with Wi-Fi hot spot deployments using access points. Tropos' products enable larger coverage areas, decreased installation costs and decreased operational costs.

Continuum Photonics

Series C in 2004
Continuum's mission is to provide optical networking equipment manufacturers with strategic subsystems that enable higher bandwidth products and associated revenue-generating services at a substantially lower cost. As a first step, Continuum Photonics is developing a radically different, operationally and economically beneficial photonic switch that will solve many of the problems associated with delivering and managing optically-transported bandwidth.

CombinatoRx

Series C in 2004
CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

Zalicus

Series D in 2004
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010, the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.

Athenix

Series B in 2004
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

Infotrieve

Series B in 2004
Infotrieve, Inc., an information management company, provides consulting and business service solutions for information centers in large and middle-market corporations. It offers librarians solutions, such as document delivery services; library staffing and information management services; STM Library, which provides real estate, technology, and personnel for collection management and document delivery for scientific, technical, and medical industries; Virtual Library 2.0, a document sourcing/delivery platform which automates and manages the document delivery process at the division or departmental level in large companies, or as an enterprise solution for a medium size or small companies; Ariel Interlibrary Loan Document Transmission Software, which turns personal computers, printers, and scanners into a document transmission station on the Internet; and copyright compliance services. The company also provides information center management solutions, such as business process outsourcing services; and Content SCM, which is designed to manage content sourcing and delivery at the enterprise level for large companies. In addition, it offers product and marketing manager’s solutions, such as reprints, eprints, and permissions services; and BRAVO, which enables colleagues separated by department, divisions, or continents to exchange communications about reprint orders in process; and eDetailing, a communication tool for pharmaceutical product and marketing managers. Infotrieve, Inc. was founded in 1987 and is headquartered in Wilton, Connecticut.

Galt Associates, Inc

Venture Round in 2004
Galt is an international leader in helping clients manage risk through information. Galt's evidence-based solutions integrate the recognized expertise of its medical and scientific personnel with innovative technologies to ensure timely answers to clients' critical questions. This integrated approach allows Galt to deliver medical risk management and communication strategies that address the benefits and risks associated with the full range of medical therapies and interventions. Galt supports more than 70 pharmaceutical, medical device and biotechnology companies, as well as contract research organizations (CRO) and research institutions located throughout the U.S. and Europe

Novalar Pharmaceuticals

Series B in 2003
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

MedAptus

Venture Round in 2003
MedAptus, Inc. provides point-of-care charge capture technologies. MedAptus offers Practice Plus Edition, a solution that is uses at single-specialty groups, multi-specialty clinics, and academic practice plans; Inpatient Edition for hospitalists, intensivists, and anesthesiologists to ease patient management tasks in addition to ensuring charge capture; EMR Edition, which is designed for physician groups; Enterprise Edition, which is designed for large groups, including academic centers and integrated delivery networks; Facility Edition that is created for hospital-based outpatient clinics to eliminate paper, manual coding and charge reconciliation, and charge data master maintenance processes from daily workflow; and Infusion Services Edition that supports the capture of infusion services and related charges allowing nurses to spend less time on paperwork and more time with patients. The company serves customers, such as smaller single specialty practices, larger multi-specialty groups, and academic medical centers. MedAptus, Inc. was formerly known as MedCompanion, Inc.

Nexidia

Series C in 2003
Nexidia has delivered a platform that unlocks the untapped value inside the massive amounts of unstructured audio and video content by making it searchable and enabling you to achieve competitive advantages, operational efficiencies, and new business opportunities.

CardioMEMS

Series B in 2003
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.

Protein Forest

Series A in 2003
Protein Forest, Inc. develops, manufactures and markets instruments, consumables, and software products to scientists for protein separation and bioanalysis applications in the United States and internationally. The company offers digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing for mass spec analysis and western blotting. Its solutions include dPC fractionator, which runs separate samples under controlled temperature, voltage, and mixing; dPC fractionator workflow, which integrates existing mass spectroscopy workflows; dPC PlugHarvestor, which allows users to select and group a set of pH gel plugs into a tube or a microplate; and bioinformatics software products. The company serves scientists in life science, drug discovery, pharmaceutical, biotech, and diagnostic industries. Protein Forest, Inc. was founded in 2002 and is based in Lexington, Massachusetts.

Collegium Pharmaceutical

Series A in 2003
Collegium Pharmaceutical is a specialty pharmaceutical company that develops and commercializes products aimed at treating chronic pain while addressing the concerns of prescription drug abuse. The company utilizes its patented DETERx platform technology to create abuse-deterrent formulations that maintain the extended-release profiles and safety of medications despite potential misuse methods such as chewing or crushing. Collegium's product lineup includes Xtampza ER, an extended-release oral formulation of oxycodone designed to deter abuse, as well as Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol respectively, for managing severe pain and acute pain in adults. Founded in 2002 and headquartered in Stoughton, Massachusetts, Collegium focuses on delivering innovative solutions for patients with chronic pain, utilizing formulation improvements backed by strong intellectual property protections.

PHT Corporation

Series E in 2003
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

Arthrosurface

Series B in 2003
Founded in 2002, Arthrosurface quickly became a globally recognized name and leader in joint preservation and replacement technology for the treatment of osteoarthritis. Arthrosurface offers anatomic, minimally invasive joint replacement solutions clinically proven to help patients stay active by increasing range of motion and reducing pain. The uniquely designed implant systems preserve native joint anatomy and maintain normal biomechanics across multiple joints. Patients can expect a short hospital stay, quick recovery, improved range of motion, reduced pain and a return to full activity levels, including CrossFit, Powerlifting or simply daily tasks necessary for an independent lifestyle. #StayActive
Odyssey Logistics & Technology (OL&T) and its subsidiaries deliver a comprehensive portfolio of managed logistics and third-party services to the global chemical and process manufacturing industries. The Odyssey Global Logistics PlatformSM is OL&T’s technology infrastructure, and features a patented proprietary net-native transportation management system that supports the safe, reliable and efficient delivery of client products throughout the world. With double digit average annual revenue growth rates for the last five years, OL&T moves products with more than $42 billion in value between 185,000 origins and destinations and 220 ports worldwide, servicing midsize to large global chemical and process industry clients.

Entigo

Venture Round in 2003
Entigo specializes in enterprise warranty chain management solutions, providing businesses with tools to streamline warranty processing. Its primary offerings include Entigo Warranty, which facilitates the management of warranty claims, and Entigo Catalyst, designed for strategic assessments of existing warranty operations. The company also offers a range of services such as project management, implementation consulting, and systems integration. These solutions aim to automate the registration and claims process, reduce error rates, and enhance analytics for informed decision-making, ultimately improving product quality and minimizing warranty costs. Entigo's systems are tailored to meet the needs of Fortune 500 manufacturers across various sectors, including automotive, aerospace, and industrial equipment. Founded in 1995 and headquartered in Exton, Pennsylvania, Entigo is committed to optimizing warranty processes and ensuring seamless integration with warranty chain partners.

Tropos Networks

Series C in 2003
Tropos Networks is a supplier of systems used to build metro-scale Wi-Fi networks. Tropos' products enable network operators, service providers and government departments to provide ubiquitous, metro-scale, broadband, wireless data coverage for users in any locale. Tropos' solution creates a truly wireless network, free from the requirement of per node wired connectivity associated with Wi-Fi hot spot deployments using access points. Tropos' products enable larger coverage areas, decreased installation costs and decreased operational costs.

NuVox

Private Equity Round in 2002
Windstream Communications provides voice and data network communications, and managed services to businesses in the United States.

Novalar Pharmaceuticals

Series A in 2002
Novalar Pharmaceuticals, Inc., a pharmaceutical company, develops oral pharmaceutical products. It focuses on dental products. The company’s OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. Novalar Pharmaceuticals, Inc. was founded in 2000 and is based in San Diego, California. As of March 22, 2011, Novalar Pharmaceuticals, Inc. operates as a subsidiary of Septodont Limited.

Nexidia

Series B in 2002
Nexidia has delivered a platform that unlocks the untapped value inside the massive amounts of unstructured audio and video content by making it searchable and enabling you to achieve competitive advantages, operational efficiencies, and new business opportunities.

TechSmart.com

Venture Round in 2002
TechSmart.com (the "Company"), formed in April 1997 under the name Linx Technologies, offers original equipment manufacturers, lessors, retailers, e-tailers and large corporations a web-based asset recovery solution ("Assets into Money") to effectively manage and resell their returned, refreshed, off-lease and overstock office technology assets ("recovered assets"). These businesses, which They call SmartPartners, send their technology assets to TechSmart.com's processing facilities where the assets are audited, tested, cleaned, packaged and remarketed through the Company's web site. Historically, businesses with recovered assets operated an inefficient in-house program in conjunction with a multi-tiered chain of "mom and pop" refurbishers, brokers, resellers and service providers. Because recovered asset management is not a core competency of these asset owners, they incurred excessive processing costs and achieved sales far below fair market value.

WebCT

Venture Round in 2002
WebCT, Inc. is the world's leading provider of e-Learning solutions for higher education. WebCT began with an educator's dream for his students: a flexible, integrated environment where he could use the latest technology to foster inquiry, encourage discourse and inspire collaboration. Today, our mission is to help institutions deliver on their commitment to educational excellence with enterprise-wide learning management solutions which integrate the richest and most flexible pedagogical tools with existing campus infrastructure. In support of that mission, we have created a family of products and services that are being used to transform the educational experience of students around the world.

PhotonEx

Series C in 2001
Photonex is the UK's showcase event dedicated to photonics and light technologies.

Athenix

Series A in 2001
Athenix is a leader in agricultural and industrial biotechnology. They have built the infrastructure necessary to discover new genes and to develop them into products that meet real customer needs.

Verio

Venture Round in 2001
Verio is the leader in providing online business solutions to SMBs worldwide. Distributed through its global network of viaVerio channel partners, Verio's solutions provide hosting, applications and managed services that enable SMBs to drive online success. Verio is a subsidiary of NTT Communications, one of the largest companies in the world and supports its operations with their highly reliable and scalable Global IP Network providing customers and partners with access to business solutions in more than 200 countries. In January 2009, Verio was named "Best Web Hosting Company 2008" by HostReview.com. For more information, visit: www.verio.com.

iParty

Venture Round in 2001
PartyCity offers consumers a supply chain that provides store locations, company history, press releases, and stock quotes.

MedAptus

Series B in 2000
MedAptus, Inc. provides point-of-care charge capture technologies. MedAptus offers Practice Plus Edition, a solution that is uses at single-specialty groups, multi-specialty clinics, and academic practice plans; Inpatient Edition for hospitalists, intensivists, and anesthesiologists to ease patient management tasks in addition to ensuring charge capture; EMR Edition, which is designed for physician groups; Enterprise Edition, which is designed for large groups, including academic centers and integrated delivery networks; Facility Edition that is created for hospital-based outpatient clinics to eliminate paper, manual coding and charge reconciliation, and charge data master maintenance processes from daily workflow; and Infusion Services Edition that supports the capture of infusion services and related charges allowing nurses to spend less time on paperwork and more time with patients. The company serves customers, such as smaller single specialty practices, larger multi-specialty groups, and academic medical centers. MedAptus, Inc. was formerly known as MedCompanion, Inc.

Sensitech

Venture Round in 2000
Sensitech® is a world leader in supply chain visibility. Their innovative monitoring products and services help to maintain the quality, integrity and security of their customers' valuable products at every step in their journey, all around the world. For more than 25 years, leading companies in the food, pharmaceutical, industrial, consumer goods, and other industries have relied on Sensitech to help protect their products—and their bottom lines.

Geyser Networks

Venture Round in 2000
As of October 12, 2001, Geyser Networks, Inc. went out of business. The company provides multi service optical solutions for the next generation optical networks. It designs and markets high-performance networking appliances including switching and routing systems. The company has developed the FlexBand™ technology, which integrates n x VT1.5 virtual concatenation, Dynamic Bandwidth Allocation (DBA) and traffic management to generate multiple TDM-like pipes for various applications. Geyser's product using this technology include: Geyser OSM 4800™ (Optical Service Manager) combines critical network elements (i.e. DWDM, MPLS Router, Ethernet Switch, IAD, etc.) into one metropolitan area networking platform; and Geyser Networks MetroView™ Network Manager System (NMS) providing a customer services management system for optical networks, linking business-level software for billing, alarm correlation, and northbound functionalities. The company was founded in 1999 and is based in Sunnyvale, California.

Totality

Series B in 2000
Totality provides application and infrastructure management services for large-scale e-commerce websites. The company is focused on solving critical needs of its clients.

PHT Corporation

Series C in 2000
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in clinical trials around the world and a rapidly growing organization. Their proven LogPad and StudyPad Systems improve data quality while Their robust StudyWorks online portal provides study sponsors, monitors and sites with real-time access to the data. With PHT, biopharmaceutical and medical device companies get better data, more data, and make faster decisions - resulting in successful trials.

InfoImage

Venture Round in 2000
InfoImage Inc. provides software solutions that automate business processes. The Company offers a variety of software tools and consulting services for use in streamlining office processes. InfoImage's products and services utilize object technology, groupware, intranets, and the Internet.

V-SPAN

Venture Round in 2000
V-SPAN is the leading video-oriented collaboration and conferencing services provider. Our portfolio includes video, audio, web and streaming for the enterprise and channel markets. Through our online self-service solutions, experienced full-service call centers and diversified global networks, V-SPAN enables its customers to conduct effective electronic meetings, events and training.

New World Communications

Venture Round in 2000
NewWorld Communications is an information technology and communications consulting firm that enables midsize businesses and enterprises to implement network, mobility, and cloud solutions. It also offers contract negotiation, strategic planning and design, project management and implementation, and support services. NewWorld Communications was acquired by Nextel Communications in January 2003. NewWorld Communications was founded in 1999 and is based in Atlanta, Georgia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.